Anticoagulant does not reduce rate of ischemic events among certain patients undergoing PCI
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes ...
Sep 1, 2013
0
0